Stemcell United Stock

Stemcell United EBIT

The EBIT of Stemcell United (SCU.AX) as of Sep 8, 2026 is -2.87 M AUD. In the previous year, EBIT was -2.26 M AUD — a change of 26.70% (lower).

EBIT

-2.87 MAUD

YoY

26.70%

Last updated:

In 2026, Stemcell United's EBIT was -2.87 M AUD, a 26.70% increase from the -2.26 M AUD EBIT recorded in the previous year.

The Stemcell United EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2015
-1.00 M AUD
Jan 1, 2016
-997,300.00 AUD
Jan 1, 2017
-836,260.00 AUD
Jan 1, 2018
-1.91 M AUD
Jan 1, 2019
-1.54 M AUD
Jan 1, 2020
-1.37 M AUD
Jan 1, 2021
-2.26 M AUD
Jan 1, 2022
-2.87 M AUD
The Stemcell United EBIT history
YEAREBITYoY
-2.87 MAUD+26.70%
-2.26 MAUD+65.27%
-1.37 MAUD-11.11%
-1.54 MAUD-19.22%
-1.91 MAUD+128.16%
-836,260.00AUD-16.15%
-997,300.00AUD-0.50%
-1.00 MAUD-111.79%
8.50 MAUD+44.07%
5.90 MAUD-10.61%
6.60 MAUD+78.38%
3.70 MAUD-54.88%
8.20 MAUD+1,950.00%
400,000.00AUD+300.00%
100,000.00AUD
Access this data via the Eulerpool API

Stemcell United Revenue

Stemcell United Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2015
6,830.00 AUD
-1.00 M AUD
75.04 M AUD
Jan 1, 2016
74,750.00 AUD
-997,300.00 AUD
-35.62 M AUD
Jan 1, 2017
31,620.00 AUD
-836,260.00 AUD
-3.63 M AUD
Jan 1, 2018
290,680.00 AUD
-1.91 M AUD
-3.35 M AUD
Jan 1, 2019
1.56 M AUD
-1.54 M AUD
-2.27 M AUD
Jan 1, 2020
730,360.00 AUD
-1.37 M AUD
-1.39 M AUD
Jan 1, 2021
8.50 M AUD
-2.26 M AUD
-2.81 M AUD
Jan 1, 2022
14.35 M AUD
-2.87 M AUD
-3.69 M AUD

Stemcell United Margins

Stemcell United stock margins

The Stemcell United margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Stemcell United. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Stemcell United.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2015
-942.17 %
-14,675.55 %
1.10 M %
Jan 1, 2016
-359.30 %
-1,334.18 %
-47,649.98 %
Jan 1, 2017
-505.25 %
-2,644.72 %
-11,483.49 %
Jan 1, 2018
-118.81 %
-656.39 %
-1,153.64 %
Jan 1, 2019
-50.84 %
-98.71 %
-145.11 %
Jan 1, 2020
-79.94 %
-187.58 %
-190.31 %
Jan 1, 2021
-6.15 %
-26.65 %
-33.12 %
Jan 1, 2022
-2.79 %
-19.99 %
-25.71 %

Stemcell United Stock analysis

What does Stemcell United do? Stemcell United Ltd is an internationally operating company that is active in the field of stem cell research and therapy. It was founded in 2005 by British entrepreneur and scientist Dr. Samantha Phillips, who previously worked for the renowned Roslin Institute for Animal Genetics. The business model of Stemcell United is based on the development and distribution of innovative therapies that are based on the use of stem cells as a foundation. The company primarily relies on close collaboration with leading research institutions and clinics worldwide to stay up to date with the latest research and develop products and services that are based on current knowledge and meet the highest quality standards. The various divisions of Stemcell United include the development and production of stem cell-based therapies for diseases such as cancer, heart attack, dementia, and stroke. Additionally, the company also offers support and consultation in the field of clinical trials as well as training for doctors and researchers to improve and optimize the use of stem cell therapies. Another important area of Stemcell United's business activities is the production and marketing of stem cells for research purposes. Both embryonic and adult stem cells are produced and provided to advance research in this field and gain new insights. The products offered by Stemcell United mainly include stem cell preparations for wound healing and tissue regeneration, as well as specialized cell cultures for research in the field of stem cell therapy. These products are sold to clinics, research institutions, and end consumers and are available in many countries worldwide. In recent years, Stemcell United has become one of the leading companies in the field of stem cell research and therapy and enjoys a high reputation in the industry. The company primarily relies on close collaboration with other top companies in the industry and a strong connection to research and development in this field. Overall, Stemcell United is an innovative and dynamic company that sets standards in the field of stem cell research and therapy worldwide and constantly seeks new ways to utilize the possibilities of stem cell therapy for the health and well-being of humans and animals. Stemcell United is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Stemcell United's EBIT

Stemcell United's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Stemcell United's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Stemcell United's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Stemcell United’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Stemcell United stock

EBIT of Stemcell United is -2.87 M AUD in 2026.

EBIT of Stemcell United changed from -2.26 M AUD to -2.87 M AUD, representing a 26.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Stemcell United since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Stemcell United historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Stemcell United

All Key Metrics — Stemcell United